Chen X[Author] - Search Results

Year	Number of Results
1979	4
1980	10
1981	16
1982	25
1983	34
1984	22
1985	37
1986	49
1987	67
1988	51
1989	55
1990	78
1991	88
1992	132
1993	155
1994	168
1995	203
1996	208
1997	230
1998	252
1999	341
2000	359
2001	445
2002	557
2003	625
2004	881
2005	1171
2006	1355
2007	1577
2008	1855
2009	2195
2010	2474
2011	2894
2012	3458
2013	4069
2014	4739
2015	5312
2016	5758
2017	6411
2018	7462
2019	8554
2020	10030
2021	11740
2022	8181
2023	6

1

Retraction Notice to: METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing.

Chen X, Xu M, Xu X, Zeng K, Liu X, Sun L, Pan B, He B, Pan Y, Sun H, Xia X, Wang S. Chen X, et al. Mol Ther. 2022 Jul 6;30(7):2640. doi: 10.1016/j.ymthe.2022.03.017. Epub 2022 May 24. Mol Ther. 2022. PMID: 35797982 Free PMC article. No abstract available.

2

Retraction notice to "Ginsenoside Rg1 protects human retinal pigment epithelial ARPE-19 cells from toxicity of high glucose by up-regulation of miR-26a" [Life Sci. 221 (2019) 152-158].

Shi Q, Chen X, Sun G, Wang L, Cui L. Shi Q, et al. Among authors: chen x. Life Sci. 2022 Sep 1;304:120736. doi: 10.1016/j.lfs.2022.120736. Epub 2022 Jun 28. Life Sci. 2022. PMID: 35778298 No abstract available.

3

Retraction Note to: Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.

Dong H, Hu J, Zou K, Ye M, Chen Y, Wu C, Chen X, Han M. Dong H, et al. Among authors: chen x. Mol Cancer. 2022 Jun 29;21(1):139. doi: 10.1186/s12943-022-01609-6. Mol Cancer. 2022. PMID: 35768868 Free PMC article. No abstract available.

4

Nanomaterial Technology and Soft Tissue Sarcomas.

Zhou C, Chen X, Huang Y, Zhang Q, Zhu S, Fu W. Zhou C, et al. Among authors: chen x. Front Oncol. 2022 Jun 22;12:921983. doi: 10.3389/fonc.2022.921983. eCollection 2022. Front Oncol. 2022. PMID: 35814363 Free PMC article. Review.

5

TF-DUBTACs Stabilize Tumor Suppressor Transcription Factors.

Liu J, Yu X, Chen H, Kaniskan HÜ, Xie L, Chen X, Jin J, Wei W. Liu J, et al. Among authors: chen x. J Am Chem Soc. 2022 Jul 20;144(28):12934-12941. doi: 10.1021/jacs.2c04824. Epub 2022 Jul 5. J Am Chem Soc. 2022. PMID: 35786952

6

Cucurbituril-based Supramolecular Polymers for Biomedical Applications.

Wang Z, Sun C, Yang K, Chen X, Wang R. Wang Z, et al. Among authors: chen x. Angew Chem Int Ed Engl. 2022 Jun 28. doi: 10.1002/anie.202206763. Online ahead of print. Angew Chem Int Ed Engl. 2022. PMID: 35762745

7

Aglycone sterics-selective enzymatic glycan remodeling.

Mao A, Zhang Y, Wang G, Zhong T, Chen X, Wang H, Xie R, Wang X, Ding L, Ju H. Mao A, et al. Among authors: chen x. iScience. 2022 Jun 13;25(7):104578. doi: 10.1016/j.isci.2022.104578. eCollection 2022 Jul 15. iScience. 2022. PMID: 35789841 Free PMC article.

8

Reactive Superhydrophobic Platform for Living Photolithography.

Xie X, Chen X, Levkin PA, Feng W. Xie X, et al. Among authors: chen x. Adv Mater. 2022 Jul 15:e2203619. doi: 10.1002/adma.202203619. Online ahead of print. Adv Mater. 2022. PMID: 35839120

9

Expert consensus on early childhood caries management.

Zou J, Du Q, Ge L, Wang J, Wang X, Li Y, Song G, Zhao W, Chen X, Jiang B, Mei Y, Huang Y, Deng S, Zhang H, Li Y, Zhou X. Zou J, et al. Among authors: chen x. Int J Oral Sci. 2022 Jul 14;14(1):35. doi: 10.1038/s41368-022-00186-0. Int J Oral Sci. 2022. PMID: 35835750 Free PMC article. Review.

10

Progress of Periosteal Osteogenesis: The Prospect of In Vivo Bioreactor.

Chen X, Yu B, Wang Z, Li Q, Dai C, Wei J. Chen X, et al. Orthop Surg. 2022 Jul 6. doi: 10.1111/os.13325. Online ahead of print. Orthop Surg. 2022. PMID: 35794789 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results